Analyst picks & changes

Amgen Inc.

(AMGN), Thousand Oaks, Calif.

Business: Biopharmaceuticals

Deutsche Bank analyst Dennis Harp raised his price target to $81 from $77 and increased his 2003 and 2004 EPS estimates

Read the full 299 word article

How to gain access

Continue reading with a
two-week free trial.